Therapeutics
Photos
Poseida Therapeutics, a member of the Roche Group, is at the forefront of innovation in cell and gene therapies, focusing on developing bold solutions to transform treatment paradigms for life-threatening cancers and genetic diseases. The company's advanced genetic engineering technologies, including a non-viral piggyBac DNA Delivery System and Cas-CLOVER Site-Specific Gene Editing System, offer promising new hope for patients through precise and effective treatments.
By targeting specific cell populations, Poseida Therapeutics aims to enhance allogeneic CAR-T therapies and seek functional cures for rare genetic diseases. Their commitment to advancing these pioneering technologies positions them as a leader in the ongoing evolution of therapeutic strategies in the medical field.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.